Retraction Note to: Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC‐1 cell apoptosis via activating the mROS‐HtrA2/Omi pathways. This evidence concerns the gene HTRA2 and pancreatic neoplasm.